year
| Category: | Pharmaceuticals and Biochemicals/Biochemicals and biotech products |
|
|
| CAS NO: | 302962-49-8 | ||
| EC NO: | |||
| Molecular Formula: | C22H28ClN7O3S | ||
| Molecular Weight: | 506.0208 | ||
| Specification: | |||
| InChI: | InChI=1/C22H26ClN7O2S.H2O/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31;/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27);1H2 | ||
| Packing: | 25kg/drum | ||
| Product description: Name Dasatinib Synonyms BMS 354825; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide CAS # 302962-49-8, Dasatinib, BMS 354825, N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide Molecular Formula C22H26ClN7O2S Molecular Weight 488.01 CAS Registry Number 302962-49-8 |
|||
| Synonyms: | intermediate;N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide hydrate (1:1);BMS 354825;N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; | ||
| Molecular Structure: |
![]() |
||